Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05306912Active, not recruiting
Single-arm trial, sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Sensitivity of targeted methylation analysis on supernatant cfDNA at Day 0. Started Apr 2022; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05306912.